Form 4 for HAE HAEMONETICS CORP
Accepted 2023-05-19 00:00:00 ET · period of report 2023-05-18 · accession 0001127602-23-016309 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-19 | 2023-05-18 | HAE | Simon, Christopher | Pres, CEO, Dir | F - Tax | $83.34 | -3,839 | 217.4K | -2% | -$319.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-18 | F | D | 3,839 | $83.34 | 217,367 | D | — | — | (F1) Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I. (F2) This number includes unvested restricted stock units previously reported. |